Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 21, 2011 - Issue 3
Submit an article Journal homepage
183
Views
5
CrossRef citations to date
0
Altmetric
Patent Evaluations

New H1/H3 antagonists for treating allergic rhinitis: WO2010094643

Peter Norman Norman Consulting, 18 Pink Lane, Burnham, Bucks, SL1 8JW, UK [email protected]
Pages 425-429 | Published online: 23 Feb 2011
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

This application claims dual receptor specificity antihistamines, active as H1 and H3 antagonists, which additionally have a long duration of action that renders them suitable for once daily administration via inhalation for the treatment of allergic rhinitis. The compounds lack CNS penetration and have a high affinity for both histamine receptors.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,757.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.